GAR Labs

GAR Labs is considered by brands that have moved beyond small-batch testing and are prepared to coordinate packaging, freight and compliance alongside a production order of at least 5,000 finished units per product.

Bottom Line

GAR Labs can be a strong candidate for established or well-funded emerging brands seeking U.S.-based hair care and skincare manufacturing, including both cold-filled products and hot-filled formats such as balms, pomades and stick deodorants.

It is less likely to fit a brand that needs a few hundred launch units, expects the manufacturer to purchase and manage every packaging component, or has not yet determined who will handle product listings, safety substantiation, claims review, freight and post-market compliance.

Key Takeaways

5,000-unit minimum

The qualifying minimum is 5,000 finished pieces per product. Bulk orders have a separate minimum of 110 gallons per product.

Packaging-first workflow

The documented process places container, label and shipping-carton selection on the buyer before finished-goods production begins.

Cold- and hot-fill capabilities

The equipment mix supports bottles, jars, tubes and selected heated-fill products, making process compatibility an important part of the evaluation.

Shared operational responsibility

Manufacturing support does not remove the brand owner’s responsibilities for claims, safety records, product listing, packaging suitability, logistics and customer-facing promises.

*Source: GAR Laboratories Official Website and FAQ | As of research conducted in August 2026 (https://www.garlabs.com/, https://www.garlabs.com/frequently-asked-questions/)

Start With the Three-Part Fit Test

A manufacturer can have suitable equipment and still be the wrong commercial partner. Before comparing unit prices, determine whether GAR Labs passes all three layers of fit.

Decision layer What GAR Labs offers What the buyer must determine
Product and process fit Hair care and skincare manufacturing, laboratory development, mixing, cold filling and dedicated hot filling. Whether the formula, viscosity, heating profile, package and intended claims fit the available process.
Commercial fit A 5,000-piece minimum per finished product, a 110-gallon bulk minimum and a 50% deposit requirement. Whether the brand can fund the complete opening commitment and sell through the inventory at a defensible rate.
Responsibility fit Manufacturing, filling, labeling, coding, case packing and palletizing after required components are received. Whether the brand can manage packaging procurement, regulatory ownership, freight, fulfillment and post-market obligations.

If any one of these layers fails, an attractive per-unit quote will not make the project operationally sound.

GAR Labs at a Glance

Company GAR Laboratories, Inc.
Location Riverside, California
Primary categories Hair care, skincare, self-tanning products, natural deodorants, pomades and balms
Finished-product minimum 5,000 pieces per product
Bulk minimum 110 gallons per product
Filling formats Cold-filled bottles, jars and tubes; dedicated hot-filled products
Deposit 50% to initiate ingredient purchasing
Freight FOB origin in Riverside; the customer arranges and pays for shipping
Published production capacity More than 100,000 pieces of combined daily production capacity

Published capacity is not the same as capacity reserved for a particular order. Confirm line availability, campaign scheduling and the production window assigned to the specific SKU.

*Source: GAR Laboratories Manufacturing, FAQ and Development Pages | As of research conducted in August 2026 (Manufacturing, FAQ, Steps for Development)

The Packaging-First Model Changes the Buyer’s Job

GAR Labs’ documented development flow begins with the package rather than the finished formula. The buyer selects the container, closure, label, shipping carton, product name and trademark, then sends the required components to the Riverside facility.

  1. Select the primary package. Determine the bottle, jar or tube, its capacity, closure and minimum purchase quantity.
  2. Develop the label and artwork. Finalize the label construction, dimensions, regulatory copy and barcode.
  3. Source shipping cartons. Confirm case count, internal dimensions and protection during distribution.
  4. Approve the product sample. Align the formula’s color, fragrance, texture and performance with the selected package.
  5. Deliver all components to GAR Labs. Manufacturing, filling, capping, coding, case packing and palletizing proceed after the necessary materials are available.

Why this can work well

Brands retain greater control over packaging aesthetics, suppliers and component economics. This can be valuable when the package is central to positioning or when the buyer already has established component vendors.

Where the risk moves

The buyer carries more responsibility for component lead times, compatibility, defects, excess inventory and inbound logistics. A late pump, cap or label can delay production even when the bulk formula is ready.

Complete these checks before issuing packaging purchase orders

  • Confirm that the proposed formula can be filled through the selected opening and dispensing system.
  • Test leakage, torque, pump output and closure performance.
  • Evaluate formula-package compatibility under expected storage conditions.
  • Confirm label dimensions, adhesion and application direction.
  • Ask who absorbs the cost of unusable, defective or over-supplied components.
  • Verify how unused packaging will be stored, returned or disposed of.
  • Do not print final claims until the formula, product classification and substantiation plan are approved.
*Source: GAR Laboratories Steps for Development and Terms and Conditions of Sale | As of research conducted in August 2026 (https://www.garlabs.com/steps-for-development/, Terms and Conditions PDF)

Choose the Formula Route Before Comparing Quotes

GAR Labs maintains prototype formulations and also accepts development inquiries based on ingredients, product samples or an existing product concept. These starting points may reduce early development friction, but they do not create the same intellectual-property position or testing burden.

Prototype-based development

A prototype formula can shorten the path to a viable texture or performance profile. It is generally most useful when speed and manufacturing practicality matter more than complete formula exclusivity.

Custom development

A custom brief can address a defined texture, fragrance, ingredient strategy or user experience. The brand should still establish the number of revisions, testing scope, ownership and exclusivity in writing.

Existing formula or benchmark

A buyer may bring an existing formula, ingredient direction or physical benchmark. Confirm whether the formula can be reproduced at production scale and whether customer-supplied materials affect warranties or liability.

“No formulation charge” does not define the full development package

GAR Labs indicates that it does not separately charge for formulation or development work and charges for the finished product. Before relying on that statement, clarify whether it includes unlimited revisions, stability testing, microbiological testing, preservative-efficacy testing, compatibility testing, claim substantiation, pilot batches and regulatory documentation.

Formula questions that require written answers

  • Who owns the formula and supporting development records?
  • Is exclusivity available, and if so, by formula, category, market or time period?
  • Can the brand transfer the formula to another manufacturer?
  • Who may authorize ingredient or supplier substitutions?
  • What tests are included in the quote, and which are separately billed?
  • What happens if the scale-up batch does not match the approved laboratory sample?

Formula ownership and exclusivity are not established by the availability of free development samples. They must be resolved in the controlling agreement.

*Source: GAR Laboratories FAQ, Product Development Information and Terms and Conditions of Sale | As of research conducted in August 2026 (FAQ, Development Process, Terms and Conditions PDF)

Budget the Opening Commitment, Not Just the MOQ

Five thousand units is only the manufacturing threshold. The real launch commitment also includes packaging purchases, testing, freight and the inventory that must be financed while the product is being produced and sold.

Initial cash exposure = manufacturing deposit + packaging commitments + testing and regulatory work + inbound freight + outbound freight + launch inventory working capital

This is an editorial planning model, not a GAR Labs pricing formula. Its purpose is to prevent a low quoted unit cost from obscuring the amount of cash required before sell-through begins.

Cost layer What to include Question to resolve
Finished goods Formula, ingredients, manufacturing, filling and agreed assembly services Which line items are included in the per-unit quote?
Packaging Containers, closures, labels, cartons, freight and potential overages Does each supplier’s MOQ match the 5,000-unit production run?
Testing Stability, microbiology, compatibility and claim-related work Which tests are required and who contracts the laboratory?
Compliance Label review, product listing, safety records and specialist advice Which party performs each task and retains the evidence?
Logistics Inbound components, pallet collection, freight insurance and fulfillment When does title and risk of loss transfer?
Working capital Deposit, final balance and inventory held before retail sell-through Can the brand finance the complete cash-conversion cycle?

A 5,000-unit order becomes more defensible when it is tied to a channel-level sales forecast, replenishment trigger and inventory exit plan—not simply a lower unit price.

Build the Schedule From Gated Milestones

The published timing references use different starting points. Sample formulation and shipment is estimated at approximately two weeks. Other materials refer to six to eight weeks after sample approval, while the current FAQ and development process identify a total estimate of approximately 10 to 12 weeks depending on ingredient availability and receipt of packaging.

These estimates are not necessarily incompatible: one may describe post-approval manufacturing while another measures the wider project. The purchase agreement should remove the ambiguity.

  1. Development begins: define the brief, package constraints, target cost and intended claims.
  2. Sample approval: identify which signed sample, specification or record becomes the production standard.
  3. Production readiness: confirm receipt and acceptance of all ingredients, containers, closures, labels and cartons.
  4. Manufacturing slot: establish when the order enters the production schedule and what can move that date.
  5. Release and pickup: define quality release, final payment, carrier appointment and transfer of risk.

A useful delivery date must have a defined start event

“Ten weeks” is incomplete unless the agreement states whether the clock starts at deposit, sample approval, packaging receipt, ingredient availability or final purchase-order acceptance.

*Source: GAR Laboratories FAQ, Homepage and Steps for Development | As of research conducted in August 2026 (FAQ, Homepage, Development Process)

Where the Equipment Fit Appears Strongest

Cold-filled products

GAR Labs describes equipment for filling and labeling bottles, jars and tubes, including aluminum and metal tube services. This can cover a broad range of hair care and skincare formats, subject to viscosity, fill-volume and component testing.

Hot-filled products

A dedicated hot-fill department supports products that must be melted and then cooled, including lip balms, stick deodorants, hair pomades and body balms. Two 10-lane serpentine cooling tunnels are used for a slower cooling process described as approximately 20 to 30 minutes.

Mixing and water systems

Published equipment includes insulated jacketed tanks, vacuum mixing capacity and automated temperature tracking. Tank information spans multiple sizes, with larger vessels reaching 3,000 gallons. Water-based products use a recirculating purification system involving deionization, ultraviolet treatment and sub-micron filtration.

Equipment availability does not prove that every formula can be processed successfully. Confirm minimum batch size, viscosity range, heating and cooling profile, shear requirements, fill tolerance, changeover controls and package compatibility for the actual SKU.

*Source: GAR Laboratories Manufacturing, Cold Filling, Hot Filling and Tank Inventory Pages | As of research conducted in August 2026 (Manufacturing, Cold Filling, Hot Filling, Tank Inventory)

How to Interpret the Listed Certifications

GAR Labs lists ISO 22716:2007, ISO 9001:2015, California Organic Processed Product Registration and California Green Business recognition. These can support supplier qualification, but none should be treated as a substitute for product-specific due diligence.

Item What it can indicate What to request
ISO 22716 Cosmetic GMP guidance covering production, control, storage and shipment Current certificate, issuer, certificate number, scope, site address and validity dates
ISO 9001 A quality-management system operating within the certified scope Current certificate and scope relevant to the services being purchased
FDA registration Potential facility-registration status under the applicable FDA framework Current registration details and confirmation of which facility performs the work
Organic registration A state registration connected with organic processed products Registration scope and whether it covers the proposed product and intended claim
Green Business certification Recognition of environmental operating practices Current status and the practices relevant to the brand’s sustainability criteria

FDA registration is not FDA approval

Cosmetic facility registration and product listing are neither product-approval programs nor promotional certifications. FDA does not issue certificates for cosmetic facility registrations or product listings.

ISO 22716 also does not establish the safety, efficacy or regulatory acceptability of an individual formula. Those questions require product-specific evidence and review.

*Source: GAR Laboratories Certificates Page, ISO 22716 and U.S. Food and Drug Administration | As of research conducted in August 2026 (GAR Laboratories Certificates, ISO 22716, FDA Registration and Listing)

U.S. Compliance Decisions to Make Before Formula Approval

Regulatory responsibilities should be assigned before artwork is printed or the production deposit is paid. A manufacturer’s regulatory guidance can support the process, but it does not automatically transfer the brand owner’s obligations.

1. Classify the product from its intended use and claims

A moisturizer marketed only to improve appearance may be a cosmetic. Claims to treat acne, prevent disease, affect the structure or function of the skin, provide sun protection or reduce perspiration can move a product into drug or cosmetic-drug regulation.

GAR Labs manufactures natural deodorant formats but expressly excludes antiperspirant deodorants from its stated capabilities. Concepts involving OTC drug claims should therefore be screened before entering the normal cosmetic-development process.

2. Identify the MoCRA responsible person

Under MoCRA, the responsible person is the manufacturer, packer or distributor whose name appears on the product label. That party has duties that can include cosmetic product listing, safety substantiation and serious adverse-event reporting.

Compliance task Required decision
Facility registration Confirm which manufacturing facility is registered and whether an exemption applies.
Product listing Assign the initial listing and annual update process.
Safety substantiation Identify which records support adequate substantiation of product safety and who retains them.
Serious adverse events Define intake, escalation, record retention and FDA reporting responsibilities.
Label contact Confirm the domestic address, phone number or electronic contact used for adverse-event reports.

Serious adverse events generally must be reported to FDA within 15 business days. New medical or other information received within one year of the initial report can trigger an additional submission within 15 business days.

3. Separate formula performance from advertising substantiation

FDA requires cosmetic labeling to be truthful and not misleading, while the FTC regulates advertising claims. A successful stability result does not, by itself, substantiate claims such as “clinically proven,” “repairs damaged skin,” “reduces inflammation” or “works for 24 hours.”

The evidence must match the exact claim, product, use conditions and target population. Ingredient-level research cannot automatically support a finished-product claim.

4. Define the testing and release package

  • Finished-product specification and approved reference sample
  • Microbiological limits and test method
  • Preservative-efficacy testing where appropriate
  • Stability protocol and acceptance criteria
  • Formula-package compatibility testing
  • Batch records and certificate-of-analysis requirements
  • Lot coding and traceability
  • Deviation, out-of-specification and recall procedures
  • Claim-substantiation evidence
  • Safety-substantiation records
*Source: U.S. Food and Drug Administration MoCRA, Registration and Labeling Guidance; Federal Trade Commission Health Products Compliance Guidance | As of research conducted in August 2026 (FDA MoCRA, FDA Registration and Listing, FDA Cosmetic Claims, FTC Compliance Guidance)

Special Review for Self-Tanning Products

GAR Labs includes DHA-based lotions, mousses, sprays and serums among its self-tanning capabilities. The format and intended use must be reviewed carefully because FDA permits DHA for external application but not for use on the lips, around the eyes, on mucous membranes, or in a manner that exposes users through inhalation or ingestion.

Topical lotions and mousses

Confirm application directions, restricted areas, color-additive compliance, package compatibility and the required warning when the product does not contain sunscreen.

Sprays and misting formats

Evaluate foreseeable inhalation, eye, lip and mucous-membrane exposure. Do not assume that a sprayable formula is automatically suitable for all-over booth or misting applications.

A sunless tanning effect does not provide sun protection. Tanning preparations that do not contain sunscreen require the applicable FDA warning statement.

*Source: GAR Laboratories Self-Tanning Manufacturing Page and U.S. Food and Drug Administration Sunless Tanner Guidance | As of research conducted in August 2026 (GAR Laboratories Skin Care and Self-Tanning, FDA Sunless Tanners, FDA Required Warning)

Contract Terms That Can Materially Change the Risk

The publicly linked Terms and Conditions document is marked “Rev. July 2021.” It is useful for identifying negotiation topics, but the buyer should request the current controlling version and reconcile it with the quotation, purchase order and any quality agreement.

Published term Commercial implication Due-diligence question
50% deposit A substantial portion of the order is funded before work begins; custom-formulation deposits are described as non-refundable. Which events make the deposit refundable, creditable or forfeited?
FOB origin Title and risk of loss may transfer when goods are loaded onto the buyer’s carrier. Who selects the carrier, purchases insurance and files transit claims?
Ingredient-supplier changes The document allows ingredient suppliers to vary because of availability. Which substitutions require written approval, testing or a new sample?
Buyer-supplied packaging Packaging supplied by the buyer is generally not warranted unless inspection and approval are separately contracted. Who approves compatibility, component quality and line performance?
Customer-supplied formulas and materials Specified customer-supplied categories are excluded from the stated guarantee or return policy. What manufacturing warranties remain when the brand supplies the formula or raw materials?
No warehousing Materials or finished goods left without open orders for more than 90 days may be subject to disposal at the buyer’s expense. What storage period, notice process and disposition instructions will apply?
Claims and indemnity The buyer assumes significant risk for customer-facing marketing promises and representations. How are label approval, claims review, product liability and recall costs allocated?
Liability limitation The linked document contains broad warranty exclusions and limitations of liability. Are the limitations acceptable relative to the order value and potential recall exposure?
Binding arbitration Disputes are directed to arbitration in Riverside, California. Has counsel reviewed the venue, procedure, cost allocation and time limits?

California Proposition 65 requires a separate brand decision

The linked terms describe a review based on ingredient lists and supplier documentation, while disclaiming independent analytical testing, exposure assessment and toxicological evaluation unless separately contracted. That type of document review is not the same as a product-specific exposure determination.

The brand should decide, with qualified counsel or a specialist where necessary, whether additional testing, exposure analysis or a warning is required for the finished product and its reasonably foreseeable use.

*Source: GAR Laboratories Terms and Conditions of Sale, Rev. July 2021 | Reviewed in August 2026 (https://www.garlabs.com/wp-content/uploads/GAR-Labs-Terms-and-Conditions-of-Sale.pdf)

What to Include in the First Request for Quote

A detailed RFQ makes quotations more comparable and exposes missing responsibilities before the deposit stage.

  • Product category and intended use
  • Target consumer and sales market
  • Desired formula route: prototype-based, custom-developed or buyer-supplied
  • Target texture, fragrance, color and sensory profile
  • Required and prohibited ingredients
  • Complete proposed claims and claim-substantiation plan
  • Expected fill volume and order quantity per SKU
  • Package drawing, material, closure and dispensing system
  • Target ex-factory cost and expected retail price
  • Required tests, specifications and documentation
  • Target sample date, production-ready date and delivery date
  • Launch states, countries and retail channels
  • Freight, warehousing and fulfillment plan
  • Formula-ownership and exclusivity requirements

Ask GAR Labs to separate the quotation into formula and ingredient cost, manufacturing, filling, labeling, coding, assembly, testing, documentation and any one-time charges. A bundled unit price is difficult to compare when the included services are not identical.

Questions to Answer Before Paying the Deposit

  1. Does the 5,000-piece minimum apply separately to every size, fragrance, shade or formula variation?
  2. What is the minimum manufacturing batch for the exact formula and fill size?
  3. Which prototype, specification and packaging sample define the approved finished product?
  4. What testing is included, and what additional testing is recommended?
  5. Who owns the formula, test data and development records?
  6. Can ingredients or suppliers change without written brand approval?
  7. Who confirms that the formula and package are compatible?
  8. What component inspection occurs before the production run?
  9. What event starts the quoted lead time?
  10. What happens if an ingredient, label or closure arrives late?
  11. What are the acceptable fill, yield and quantity tolerances?
  12. What documentation accompanies each released batch?
  13. Who completes MoCRA product listing and annual updates?
  14. How are complaints, serious adverse events and recalls handled?
  15. Which warranties and remedies apply to the specific order?
  16. When does title and risk of loss transfer?
  17. What is the current cancellation, storage and disposal policy?
  18. Which agreement controls if the quote, purchase order and standard terms conflict?

When GAR Labs Is Likely to Be a Strong Candidate

Consider GAR Labs when:

  • The brand can support at least 5,000 units per product.
  • U.S.-based manufacturing is commercially important.
  • The range includes hair care, skincare, balms, pomades or natural deodorants.
  • The product needs cold filling or a dedicated hot-fill process.
  • The buyer is prepared to manage packaging vendors and freight.
  • The team can define regulatory and quality responsibilities contractually.

Compare additional manufacturers when:

  • The launch requires a few hundred or a few thousand units.
  • The brand needs one supplier to procure all packaging and deliver finished goods to fulfillment.
  • Cash flow cannot support the deposit, packaging orders and inventory cycle.
  • The project involves antiperspirant or another OTC drug category.
  • The brand requires clearly documented formula ownership or exclusivity before development.
  • International regulatory support is central to the launch.

The Reasonable reason to shortlist GAR Labs is not simply that it can manufacture cosmetics. It is that its batch scale, filling equipment and buyer-managed operating model match the brand’s actual stage of growth.

Frequently Asked Questions

Is GAR Labs a private label or custom manufacturer?

It supports development from existing prototype formulations as well as more customized product briefs. Buyers should confirm how much each starting formula can be modified and whether exclusivity is available.

Is GAR Labs suitable for a startup?

It may fit a well-funded startup with validated demand and sufficient working capital. It is not positioned as a small-batch manufacturer: the stated finished-product minimum is 5,000 pieces per product.

Does the 5,000-unit minimum include multiple variants?

The published minimum is stated per product. Whether different fragrances, shades, sizes or label versions can be combined is not established and should be confirmed in the quotation.

Does free formulation include all required testing?

Not necessarily. The absence of a separate formulation charge does not establish that stability, microbiological, compatibility or claim testing is included. Obtain an itemized testing schedule.

Who owns a formula developed by GAR Labs?

Formula ownership and transfer rights are not sufficiently defined by the general development information. Resolve ownership, confidentiality, exclusivity and transfer rights in the controlling agreement.

Does GAR Labs provide warehousing and fulfillment?

Its shipping information refers buyers to third-party logistics and warehousing providers. Brands that require direct-to-consumer or retailer fulfillment should contract and budget for that function separately.

How should GAR Labs be compared with another manufacturer?

Compare total opening cash exposure, formula rights, included testing, responsibility allocation and delivery milestones—not only MOQ and quoted unit price.

Final Assessment

GAR Labs presents a credible manufacturing option for brands that need meaningful production volume, established hair care or skincare processing and access to both cold- and hot-fill equipment in Southern California.

The principal decision is operational rather than promotional. A brand must be ready to purchase and coordinate packaging, fund a 50% deposit, arrange freight, define its regulatory role and negotiate protections around formula rights, substitutions, testing, warranties and liability.

Recommended next step

Request a product-specific quotation, current certificates, the current controlling terms, a written testing schedule and a responsibility matrix. Compare those documents with at least two manufacturers using the same RFQ before selecting a partner.

Discuss a Project With GAR Labs

Send a defined product brief, package specifications, target quantity, claims and required launch date to obtain a commercially meaningful response.

GAR Laboratories, Inc. | 1844 Massachusetts Ave., Riverside, CA 92507 | 951-788-0700 | info@garlabs.com

This page is intended to support manufacturer due diligence and does not constitute legal or regulatory advice. Requirements and contractual terms should be reviewed for the specific product, market and transaction.